Bilateral vitreous hemorrhages as a consequence of thrombolytic therapy successfully treated with vitrectomy in a patient without diabetes

Am Heart J. 1995 Sep;130(3 Pt 1):611-2. doi: 10.1016/0002-8703(95)90371-2.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Diabetes Mellitus
  • Humans
  • Male
  • Myocardial Infarction / complications
  • Myocardial Infarction / drug therapy
  • Thrombolytic Therapy / adverse effects*
  • Tissue Plasminogen Activator / administration & dosage
  • Tissue Plasminogen Activator / adverse effects*
  • Vitrectomy*
  • Vitreous Hemorrhage / chemically induced*
  • Vitreous Hemorrhage / surgery

Substances

  • Tissue Plasminogen Activator